| Name | Title | Contact Details |
|---|
Mid-Atlantic Crossroads is a College Park, MD-based company in the Education sector.
SUNY Cortland is a 7,000-student comprehensive college of arts and sciences located in the rolling hills of Central New York. It has been educating ambitious students since 1868, and has graduated more than 70,000 alumni success stories in fields ranging from education, science and business to athletics, entertainment and the arts. Providing a high-quality educational environment where students learn in the classroom, the community and beyond is our top priority. We are home to the largest and most-respected teacher education program in New York state, one of the country`s top Division III athletic programs, and an ever-growing collection of national honors and accolades for educational value, sustainability leadership, programmatic excellence and service to communities beyond campus. But the value of SUNY Cortland`s educational experience runs much deeper than that. Cortland helps shape the character, philosophy and attitude of its students as it expands their horizons far beyond the classroom. As a result, Cortland alumni think critically and independently. They`re not afraid to test perceived limits. They`ve developed the confidence to persevere in the face of challenges and to lead in times of crisis or confusion.
Academy Canada Inc. is a Corner Brook, NL-based company in the Education sector.
SUNY Plattsburgh was founded in 1889 as an institution of higher education with the sole mission of training teachers. Today, it is a comprehensive college that offers a traditional liberal arts foundation with more than 70 majors including a broad array of accredited professional programs. The college enrolls approximately 5,350 undergraduates and 400 graduate students.
HistoSonics Inc. is a new medical device company that is developing Histotripsy, a non-invasive image guided and robotic tissue excision technology that was licensed from the University of Michigan. Histotripsy is a versatile platform that will replace traditional surgical and minimally invasive methods to reduce patient trauma and health care costs. The first clinical application will be treatment of Benign Prostatic Hyperplasia (BPH), a prevalent condition in senior men. The condition affects over two million men in the US and approximately 400,000 are treated surgically each year.